Pharmaceutical company Galderma has announced that the US Food and Drug Administration (FDA) has approved Restylane Lyft for the augmentation for the chin region. The company shares that the combination
The landscape of facial aesthetics is undergoing a significant transformation, with an increasing number of patients favouring a ‘less is more’ philosophy. Aesthetic nurse prescriber Michelle McLean, owner of Aesthetically You clinic, has found that rather than prioritising excessive volume …
Subscriber content
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
Pharmaceutical company Galderma hosted their Inaugural GAIN (Galderma Aesthetic Injector Network) event in Geneva, Switzerland, highlighting what transformational aesthetic journeys look like for different patients.
Pharmaceutical company Galderma will host an exclusive webinar in partnership with the Aesthetics journal.
Discover the ultimate 3D facial profiling technique with Restylane Lyft, Volyme and Defyne
Global pharmaceutical company Galderma has started a new campaign that will offer clinics a mix of expert training, guidance, offers, and clinic campaign assets.
A survey conducted by online resource RealSelf found that the top-ranked non-surgical treatment was the diVa vaginal therapy, a laser used to address changes in vaginal health, with a ranking of 100%.
Pharmaceutical company Galderma (UK) Limited has begun a review of its distribution arrangements and announced plans to appoint one preferred distributor for its Azzalure and Restylane brands.
Due to unforeseen circumstances, The Anatomy of the Smile Webinar sponsored by pharmaceutical company Galderma has been postponed until March 11.
